Zydus Nycomed Healthcare, a 50:50 joint venture company set up by Ahmedabad-based Zydus Cadila and European pharma firm Nycomed, will become the key raw material sourcing hub for Nycomed.Nycomed will transfer the production of 18 active pharmaceutical ingredients (APIs) from its facilities at Linz (Austria) and Singen (Germany) to Zydus Nycomed in India over four years. The partners signed an agreement expanding the scope of their collaboration today.Zydus Nycomed was set up in 1999 to manufacture key starting materials for the production of Pantoprazole at the state-of-the-art plant in Navi Mumbai.Pankaj R Patel, chairman and managing director, Zydus Cadila, said: "The need to create a centre of excellence that sets the highest global standards in quality and service has been the very basis of this partnership. The new avenue that we have opened up strengthens this premise, and will add a new dimension to the mutually beneficial partnership that exists between the two companies."
